BIO KEY INTERNATIONAL INC - 8-K Filing
BIO-key International Inc.'s common stock will be suspended from Nasdaq trading on May 13, 2026 due to failure to maintain compliance with the $1 minimum closing bid price requirement for ten consecutive days by May 4 and not filing its Annual Report on Form 10-K. The company plans to request a hearing before a Nasdaq Hearings Panel but cannot guarantee reinstatement. Shares will trade on OTC Markets under ticker BKYI. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $BKYI